Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

Completed1
unknown1
Recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

completed125%
unknown125%
recruiting125%
suspended125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

NCT07427017
suspendednot_applicable

Selenium as Augmentation Treatment for Sertraline Resistant Major Depression

NCT02890212
completednot_applicable

Effect of Selenium Supplementation on Influenza Vaccination

NCT04188483
unknownnot_applicable

Correction of Selenium Deficiency Has Effect on Thyroid Function

NCT03445078

Clinical Trials (4)

Showing 4 of 4 trials
NCT07427017Phase 2

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Recruiting
NCT02890212Not Applicable

Selenium as Augmentation Treatment for Sertraline Resistant Major Depression

Suspended
NCT04188483Not Applicable

Effect of Selenium Supplementation on Influenza Vaccination

Completed
NCT03445078Not Applicable

Correction of Selenium Deficiency Has Effect on Thyroid Function

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4